Chemed CORP Form 4 insider transactions

Brian C. Judkins, VP and Chief Legal Officer of Chemed Corp, reports the acquisition of 10,323 stock options on October 22, 2024.

Executive Vice President Spencer S. Lee acquired 9,105 stock options in Chemed Corp on October 22, 2024.

Michael D. Witzeman, VP & Chief Financial Officer of Chemed Corp, reports acquisition of stock options.

Nicholas Michael Westfall, Executive Vice President of Chemed Corp, reports acquisition of stock options.

Chemed Corp's CEO, Kevin J. McNamara, acquired 40,332 stock options on October 22, 2024, exercisable starting October 22, 2025.

Chemed Corp's CEO, Kevin J. McNamara, sold 2,000 shares of company stock at an average price of $598.81 on September 26, 2024.

Director George J. Walsh III of Chemed Corp (CHE) sold 400 shares of Capital Stock on September 26, 2024, at a price of $597.47 per share.

Nicholas Michael Westfall, Executive Vice President of Chemed Corp, sold 1,713 shares of capital stock at an average price of $569.35 on September 9, 2024.

Nicholas Westfall, Executive Vice President of Chemed Corp, exercised stock options and disposed of shares to cover the purchase price and tax obligations on September 4, 2024.

Director Andrea R. Lindell sold 831 shares of Chemed Corp (CHE) at a price of $571.51 on August 16, 2024.

Director George J. Walsh III of Chemed Corp reported the sale of 200 shares of Capital Stock on August 21, 2024.

Thomas C. Hutton, a director and Vice President of Chemed Corp, amended a previous SEC filing to report the disposal of 4,827 shares of Capital Stock at a price of $576.32 on August 7, 2024.

Executive Vice President Spencer S. Lee reports stock sales and option exercises at Chemed Corp.

Thomas C. Hutton, Vice President of Chemed Corp, sold 4,827 shares of Capital Stock on August 6, 2024, at a price of $576.32 per share.

Chemed Corp's CEO, Kevin McNamara, reports exercising stock options and selling shares on August 5, 2024.

Chemed Corp's VP & Chief Financial Officer, Michael D. Witzeman, executed stock options and disposed of shares to cover the purchase price and tax obligations.

Nicholas Westfall, Executive Vice President of Chemed Corp, amended a previous filing to report a sale of 2,000 shares of capital stock at an average price of $561.58.

Nicholas Michael Westfall, Executive Vice President of Chemed Corp, sold 2,000 shares of capital stock at an average price of $561.58 on July 30, 2024.

Director Patrick P. Grace sold 284 shares of Chemed Corp stock at an average price of $540.98 on June 12, 2024.

Chemed Corp's CEO, Kevin J. McNamara, sold 1,500 shares of capital stock at an average price of $544.17 on June 6, 2024.

Director George J. Walsh III acquired 284 shares of Chemed Corp capital stock at $564.34 per share on May 20, 2024.

Director Thomas P. Rice acquired 284 shares of Chemed Corp capital stock at a price of $564.34 per share on May 20, 2024.

Director John Meredith Mount Jr. acquired 284 shares of Chemed Corp stock at $564.34 per share on May 20, 2024.

Director Eileen P. McCarthy acquired 284 shares of Chemed Corp capital stock on May 20, 2024.

Director Andrea R. Lindell acquired 284 shares of Chemed Corp capital stock at $564.34 per share on May 20, 2024.

Director Christopher J. Heaney acquired 284 shares of Chemed Corp capital stock at $564.34 per share on May 20, 2024.

Director Patrick P. Grace acquired 284 shares of Chemed Corp on May 20, 2024.

Director Ron DeLyons acquired 284 shares of Chemed Corp capital stock at $564.34 per share on May 20, 2024.

Chemed Corp's CEO, Kevin McNamara, sold 4,000 shares of company stock at an average price of $567.54 on May 16, 2024.

VP & Chief Financial Officer of Chemed Corp, Michael D. Witzeman, reports acquisition and disposal of company stock and stock options on May 7, 2024.